|
|
|
|
|
-
Daniel Hayden, Senior Vice President & General Manager, Genzyme Pharmaceuticals, talks about Genzyme-DSM partnership
-
David Linn, Sr. Director, Marketing, talks about DSM at BIO 2010
-
Hank Nowak, Director, Business Development talks about DSM solid dosage forms
-
Karim Abdelkader, Director, New Business Development talks about DSM steriles at BIO 2010
-
PharmaTelevision Special Report on DSM Pharmaceutical Products
-
Paul Sidhu, Vice President, Marketing & Strategy, talks about the revolution in biomanufacturing
-
Rolf Douwenga, Vice President R&D, talks about XD® Technology
-
Fritjof Linz, Senior Director, Business Development & Marketing, talks about DSM Biologics technology and RHOBUST®
-
Spencer Reynolds, Director, New Business Development, talks about RHOBUST®
-
David Hughes, CEO of BioPharmaceuticals Australia
-
Dr. Anna Lavelle, CEO of AusBiotech Ltd
-
Queensland Premier, Hon. Anna Bligh, and Karen King, President DSM Biologics, discuss partnership for new drug manufacturing facility in Brisbane
-
Australian Government announces plans to build biopharmaceutical manufacturing facility in Brisbane
-
Laura Parks, Senior Vice President, Marketing & Sales, DSM Pharmaceuticals, Inc. at the World Vaccine Congress
-
Karen King, President, DSM Biologics on DCAT TV
-
View award ceremony at Informex
-
DSM Pharma Chemicals at Informex on YouTube
-
DSM Pharmaceuticals at Informex on YouTube
-
Profiles in Sustainability Awards on YouTube
-
Pieter de Geus, Ph.D., Senior Vice President, Research and Development “100 Years of Innovation”
-
Pharma Dosage facilities in Greenville, NC, USA
-
Biomanufacturing in Groningen, NL
-
Large scale API & Intermediate production in Linz, Austria
|
|
|
|
|
|
|
|
|
|
